omg I can’t believe the dribble that people come up with SML stated that nutritional products demand was diminished as it should be due to the waiting china approval approval
a2 is allowed to sell the remaining stock while it awaits china approval sml have not dropped the ball it has provided an update and it awaits approval simple is not ever a word in china the process is long as it should be as this creates a moat
I’ll say this the china regulators have allows the nz food regulators to make the decision sounds like a win to me be patient
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)